CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: Our results demonstrated that miR‐429 expression was negatively correlated with CRKL expression, and the dysexpressions of CRKL and miR‐429 were closely correlated in affecting CML malignancy.